Business Context and Reporting Period
This Form 8-K filing by GRI Bio, Inc. (GRI) reports on a Special Meeting of Stockholders held on February 11, 2025. The meeting was conducted virtually to address corporate governance matters, specifically regarding the company's capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the results of a stockholder vote and does not contain financial performance data.
Material Changes and Voting Results
As of the record date of January 6, 2025, the company had 8,933,366 shares of common stock issued and outstanding. A quorum of 4,640,469 shares (approximately 51.94%) was present or represented by proxy. Two proposals were approved by a majority of votes cast:
- Proposal 1 (Reverse Stock Split): Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split. The ratio is set within a range of not less than 1-for-2 and not more than 1-for-23. The Board of Directors retains sole discretion to set the exact ratio or abandon the split entirely.
- Votes For: 3,151,775
- Votes Against: 1,484,078
- Votes Abstained: 4,616
- Proposal 2 (Adjournment): Stockholders approved the ability to postpone or adjourn the meeting to solicit additional proxies if necessary for Proposal 1.
- Votes For: 3,237,240
- Votes Against: 1,390,423
- Votes Abstained: 12,806
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the context of the stockholder vote. The primary contingency noted is the Board's discretion to determine the final reverse stock split ratio or to abandon the split entirely despite stockholder approval of the authorization.
Key Facts for Investor Verification
- Verify the specific reverse stock split ratio selected by the Board of Directors, as the filing only authorizes a range (1-for-2 to 1-for-23).
- Confirm the effective date of the reverse stock split, which is not specified in this filing.
- Review the Definitive Proxy Statement filed on January 17, 2025, for detailed rationale and implications of the proposed amendment.
- Monitor subsequent filings for the official implementation of the reverse split or any announcement regarding its abandonment.